State Street Corp lifted its holdings in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) by 7.5% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 56,252 shares of the medical instruments supplier’s stock after buying an additional 3,943 shares during the quarter. State Street Corp owned about 1.50% of Mesa Laboratories worth $8,063,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of the company. PNC Financial Services Group Inc. grew its position in shares of Mesa Laboratories by 2.3% during the 2nd quarter. PNC Financial Services Group Inc. now owns 3,117 shares of the medical instruments supplier’s stock worth $446,000 after buying an additional 71 shares during the period. Strs Ohio grew its position in shares of Mesa Laboratories by 5.6% during the 2nd quarter. Strs Ohio now owns 1,900 shares of the medical instruments supplier’s stock worth $272,000 after buying an additional 100 shares during the period. Swiss National Bank grew its position in shares of Mesa Laboratories by 9.6% during the 2nd quarter. Swiss National Bank now owns 5,702 shares of the medical instruments supplier’s stock worth $817,000 after buying an additional 500 shares during the period. Wells Fargo & Company MN grew its position in shares of Mesa Laboratories by 19.9% during the 2nd quarter. Wells Fargo & Company MN now owns 3,326 shares of the medical instruments supplier’s stock worth $476,000 after buying an additional 553 shares during the period. Finally, Teachers Advisors LLC grew its position in shares of Mesa Laboratories by 14.9% during the 2nd quarter. Teachers Advisors LLC now owns 5,660 shares of the medical instruments supplier’s stock worth $811,000 after buying an additional 733 shares during the period. Institutional investors own 69.74% of the company’s stock.

Several equities research analysts have recently commented on the stock. TheStreet upgraded shares of Mesa Laboratories from a “c+” rating to a “b” rating in a research report on Monday, November 6th. Zacks Investment Research raised shares of Mesa Laboratories from a “strong sell” rating to a “buy” rating and set a $167.00 price objective on the stock in a research note on Tuesday, October 3rd. Finally, BidaskClub lowered shares of Mesa Laboratories from a “sell” rating to a “strong sell” rating in a research note on Saturday, August 12th.

Mesa Laboratories, Inc. (NASDAQ:MLAB) opened at $134.80 on Thursday. Mesa Laboratories, Inc. has a one year low of $113.57 and a one year high of $169.80. The firm has a market cap of $510.08, a P/E ratio of 35.70 and a beta of 0.49. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.97 and a current ratio of 2.86.

Mesa Laboratories (NASDAQ:MLAB) last released its quarterly earnings data on Monday, November 6th. The medical instruments supplier reported $0.60 earnings per share for the quarter, missing the consensus estimate of $0.64 by ($0.04). Mesa Laboratories had a return on equity of 14.77% and a net margin of 11.48%. The firm had revenue of $22.95 million for the quarter, compared to the consensus estimate of $25.50 million. analysts forecast that Mesa Laboratories, Inc. will post 2.47 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 15th. Investors of record on Thursday, November 30th will be paid a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 0.47%. The ex-dividend date is Wednesday, November 29th. Mesa Laboratories’s payout ratio is 23.10%.

TRADEMARK VIOLATION NOTICE: “State Street Corp Has $8.06 Million Stake in Mesa Laboratories, Inc. (MLAB)” was first posted by Watch List News and is owned by of Watch List News. If you are reading this article on another publication, it was illegally copied and reposted in violation of US & international copyright laws. The original version of this article can be viewed at https://www.watchlistnews.com/state-street-corp-has-8-06-million-stake-in-mesa-laboratories-inc-mlab/1734369.html.

About Mesa Laboratories

Mesa Laboratories, Inc is focused primarily on quality control products and services. The Company operates through four segments: Instruments, Continuous Monitoring, Biological Indicators and Cold Chain. The Instruments Division designs, manufactures and markets quality control instruments and disposable products.

Institutional Ownership by Quarter for Mesa Laboratories (NASDAQ:MLAB)

Receive News & Ratings for Mesa Laboratories Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesa Laboratories Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.